MediClin AGSTU:MED +1.04%77 Days Payable is 34.97 as of Mar. 2026, which is 22% below its 10-year median of 45.05. GuruFocus rates STU:MED with a GF Score™ of 77/100 and a GF Value™ of €2.95 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 607 Healthcare Providers & Services companies, MediClin AG ranks worse than 72.98% on this metric.
The historical rank and industry rank for MediClin AG's Days Payable or its related term are showing as below:
STU:MED'
s Days Payable Range Over the Past 10 Years
Min: 32.19 Med: 45.05 Max: 52.34
Current: 32.19
During the past 13 years, MediClin AG's highest Days Payable was 52.34. The lowest was 32.19. And the median was 45.05.
STU:MED's Days Payable is ranked worse than 72.98% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 58
vs STU:MED: 32.19
MediClin AG's Days Payable
declined
from Mar. 2025 (41.91) to Mar. 2026 (34.97).
It may suggest that MediClin AGaccelerated paying its suppliers.
MediClin AG Days Payable Related Terms
MediClin AG Days Payable Historical Data
* Premium members only.
The historical data trend for MediClin AG's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, MediClin AG's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MediClin AG Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MediClin AG's Days Payable distribution charts can be found below:
* The bar in red indicates where MediClin AG's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
MediClin AG's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MediClin AG (STU:MED) has a Days Payable of 34.97 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on MediClin AG and its competitors. This is 22% below median its historical median of 45.05. Over the past decade, MediClin AG's Days Payable has ranged from 32.19 to 52.34. According to the industry distribution chart, MediClin AG ranks #443 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 73%.
Is MediClin AG's Days Payable too high?
MediClin AG's current Days Payable of 34.97 is 22% below median its 10-year median of 45.05. Over the past 10 years, this metric has ranged from a low of 32.19 to a high of 52.34. The Healthcare Providers & Services industry median Days Payable is 58.00. MediClin AG's value of 34.97 is 39.7% below this industry median. Based on the distribution chart, MediClin AG ranks #443 out of 607 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, MediClin AG has a GF Score™ of 77/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does MediClin AG's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, MediClin AG ranks #443 out of 607 companies for Days Payable. This places MediClin AG in the lower half of its industry. The industry median Days Payable is 58.00. MediClin AG's value of 34.97 is 39.7% below this benchmark. Historically, MediClin AG's own Days Payable has ranged from 32.19 to 52.34 over the past decade. While the company's 10-year median is 45.05 vs. the industry median of 58.00, MediClin AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.00, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MediClin AG's current Days Payable of 34.97 is 39.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on MediClin AG and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MediClin AG's current Days Payable is 34.97, which is 22% below median its own 10-year median of 45.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MediClin AG stock overvalued right now?
Based on GuruFocus' analysis, MediClin AG (STU:MED) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.95, compared to a current price of €3.88 — trading 31.5% above its estimated fair value. The current Days Payable is 34.97, which is 22% below median its 10-year median of 45.05 and 39.7% below the Healthcare Providers & Services industry median of 58.00. MediClin AG's overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For MediClin AG (STU:MED), the current Days Payable is 34.97 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MediClin AG (STU:MED) Overvalued in 2026?
Based on GuruFocus' analysis, MediClin AG stock appears to be overvalued.
The current stock price of €3.88 is trading 31.5% above its estimated GF Value™ of €2.95.
GuruFocus considers MediClin AG to be Significantly Overvalued.
Key valuation signals for STU:MED:
Days Payable: 34.97 (22% below median its 10-year median of 45.05)
GF Value™: €2.95 vs. price of €3.88 (31.5% above fair value)
Industry Position: 39.7% below the Healthcare Providers & Services median (#443 of 607)
No single metric tells the full story. See the STU:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MediClin AG operates hospitals and other medical care centers. The company's reportable operating segments are the Post-acute, Acute, Nursing care, and Service segments. A majority of its revenue is generated from the Post-acute segment, which offers services in the fields of follow-up rehabilitation treatment and curative treatment. Some of the post-acute hospitals also offer services in acute neurology and acute psychosomatics. The Acute segment encompasses medical offerings with a focus on neurology and neurological early rehabilitation as well as psychosomatic medicine, psychiatry, orthopaedics, and internal medicine. The Nursing care segment offers full-time and part-time nursing care as well as daycare, and the Service segment consists of the central services.
77GF Score
Get the complete analysis for STU:MED
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:MED has been successfully added to your 
